Evan Kearns serves as Executive at Cogent Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Evan Kearns has executed 4 insider transactions totaling $2.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 26, 2025 involved selling 65,000 shares valued at $2.5M.
Evan Kearns currently holds 109,398 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Evan Kearns has been a net seller of COGT stock. They have purchased $0 and sold $2.5M worth of shares.
Evan Kearns's most recent insider trade was on Dec 26, 2025, when they sold 65,000 shares at $38.70 per share.
Get notified when new Form 4 filings are submitted
| $39.45 |
| Discretionary |
| Dec 17, 2025 | COGT | $0 | Award | 260,000 | $N/A | Discretionary |
| Dec 17, 2025 | COGT | $0 | Award | 40,000 | $N/A | Discretionary |